WALTHAM, Mass. & SHANGHAI--(BUSINESS WIRE)--Ensem doses first patient in China in ETX-636 global Phase 1/2 study in cancer patients with activating PI3Kα mutations, including breast cancer ... .
Swipe or click to see more. East Texas Trekkers Inc ... at Tyler State Park... This is one of multiple stories in ETXView’s 2026 January/February issue that published Jan ... To read more stories and view the full digital edition, visit our ETX View homepage ... .
Swipe or click to see more. Victor Lopez, left, Aurelia Espino, Guillermo Espino and Rene Espino Thursday, December 11, 2025, at El Taquito Taqueria in SouthLongview. (Les Hassell/News-Journal Photo). Swipe or click to see more ...Family ... .
Swipe or click to see more. Owner JoelleJackson can give customers a first look at their construction dreams at Walk Your Plans Tuesday, Dec. 9, in Tyler. (Les Hassell/ETXView). Swipe or click to see more ... (Les Hassell/News-Journal Photo) ... How it works ... .
Swipe or click to see more. NEW BEGINNING ... (Contributed Photo) ... AFTER ... AFTER ... This is one of multiple stories in ETXView’s 2026 January/February issue that published Jan ... To read more stories and view the full digital edition, visit our ETX View homepage.
FDA for evaluation of ETX-19477 in patients with BRCA-mutated, platinum-resistant ovarian cancer – ...Food and Drug Administration (FDA) has granted Fast Track designation to ETX-19477, the company’s internally discovered PARG inhibitor ... About ETX-19477.